Filing Details

Accession Number:
0001140361-23-012884
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-21 21:00:25
Reporting Period:
2023-03-17
Accepted Time:
2023-03-21 21:00:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1305253 Eiger Biopharmaceuticals Inc. EIGR Biological Products, (No Disgnostic Substances) (2836) 361004130
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1686952 Iii C. Eldon Mayer C/O Eiger Biopharmaceuticals, Inc.
2155 Park Blvd.
Palo Alto CA 94306
Ex Vp & Chief Commerc. Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-03-17 2,520 $1.07 57,948 No 4 S Direct
Common Stock Disposition 2023-03-17 1,875 $1.07 56,073 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. These shares were sold by the reporting person in a pre-elected sell-to-cover transaction to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units ("RSUs") granted on March 11, 2022 for 16,000 shares.
  2. These shares were sold by the reporting person in a pre-elected sell-to-cover transaction to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 12, 2021 for 11,875 shares.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.07 to $1.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.